Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
